Keytruda Benefits Reported at AACR for Advanced Small Cell Lung Cancer

The anti-PD-1 monoclonal antibody immunotherapy pembrolizumab (Keytruda) is FDA approved to treat multiple types of cancer including melanoma, classical Hodgkin lymphoma, advanced cervical cancer,...

Omega-3 Deficiency Underlies Peripheral Artery Disease

A new study from a team of investigators at the University of California, San Francisco (UCSF) has just published evidence showing that individuals diagnosed...

Potential Leukemia Drug Target Found in Epigenetic Protein

Acute myeloid leukemia (AML) is an aggressive cancer that led to over 10,000 deaths in the United States last year. While AML is the...

Gut Microbiome Helps Warm the Cockles of Your Core

During cold exposure, it is well established that animals sustain their body temperature by activating heat production from a specialized tissue known as brown adipose tissue and promoting "browning" of white adipose tissue. Now, investigators have revealed the important role of gut microbiota in thermoregulation and adipose breakdown.

Cell-Free Protein Synthesis Made Flexible and Accessible

Researchers say they greatly simplified the method for cell-free protein synthesis

Metabolic Enzyme Pathway Identified as Potential Colon Cancer Target

University of Massachusetts (UMass) Amherst food scientists have identified a set of metabolic enzymes that are upregulated in colon cancer-bearing mice and in human...

Immunotherapy for Egg Allergy Shows Promise in Long-Term Study

Researchers and clinicians in attendance at the annual American Academy of Allergy, Asthma, and Immunology (AAAAI) conference are readily cognizant to the widespread impact...

Top 10 Immuno-Oncology Startups

GlaxoSmithKline (GSK)’s recently announced $4.2 billion partnership to co-develop and co-commercialize Merck KGaA, Darmstadt’s cancer immunotherapy candidate M7824 was a reminder of just how...

Stroke Recovery May Be Assisted by HIV Drug, Suggests Study of...

Hints have been accumulating that maraviroc, a drug for slowing HIV, could benefit patients who have suffered mild stroke. A few years ago, maraviroc...

Triclosan Added to Consumer Products Dramatically Decreases Antibiotic Efficacy

New research finds a chemical that is supposed to kill bacteria is making them stronger and more capable of surviving antibiotic treatment. The study suggests that triclosan exposure may inadvertently drive bacteria into a state in which they are able to tolerate normally lethal concentrations of antibiotics.

Recently Featured

Stay Connected

557,076FansLike
47,067FollowersFollow
Scroll Up